Visual Outcomes and Patient Satisfaction After Bilateral Refractive Lens Exchange With a Trifocal Intraocular Lens in 5,226 Patients With Presbyopia.

IF 2.9 3区医学 Q1 OPHTHALMOLOGY

Journal of refractive surgery Pub Date : 2024-07-01 DOI:10.3928/1081597X-20240517-01

Andrea Llovet-Rausell, Julio Ortega-Usobiaga, César Albarrán-Diego, Jaime Beltrán-Sanz, Rafael Bilbao-Calabuig, Fernando Llovet-Osuna

{"title":"Visual Outcomes and Patient Satisfaction After Bilateral Refractive Lens Exchange With a Trifocal Intraocular Lens in 5,226 Patients With Presbyopia.","authors":"Andrea Llovet-Rausell, Julio Ortega-Usobiaga, César Albarrán-Diego, Jaime Beltrán-Sanz, Rafael Bilbao-Calabuig, Fernando Llovet-Osuna","doi":"10.3928/1081597X-20240517-01","DOIUrl":null,"url":null,"abstract":"Purpose: To assess visual and refractive outcomes and visual function after bilateral RayOne Trifocal toric and nontoric intraocular lens (IOL) (Rayner) implantation in patients with presbyopia.Methods: Charts of patients with presbyopia who underwent refractive lens exchange with bilateral implantation of the RayOne Trifocal IOL (toric and non-toric) were retrospectively reviewed. Visual and refractive outcomes were evaluated at 3 months. Patient satisfaction, spectacle independence, and visual disturbance profile were assessed by questionnaires.Results: A total of 5,226 patients were assigned to one of two groups: 1,010 patients had toric IOL implantation (toric group) and 4,216 patients received the non-toric model (non-toric group). Mean ± standard deviation visual acuity at 3 months for the toric group was binocular uncorrected distance visual acuity (UDVA) of 0.07 ± 0.11 logMAR, monocular corrected distance visual acuity (CDVA) of 0.05 ± 0.07 logMAR, binocular uncorrected near visual acuity (UNVA) at 40 cm of 0.10 ± 0.09 logMAR, binocular uncorrected intermediate visual acuity (UIVA) at 40 cm of 0.13 ± 0.12 logMAR, postoperative spherical equivalent (SE) of -0.21 ± 0.47 diopters (D), and cylinder of -0.34 ± 0.40 D. The non-toric group had binocular UDVA of 0.04 ± 0.08 logMAR, monocular CDVA of 0.05 ± 0.07 logMAR, binocular UNVA of 0.10 ± 0.08 logMAR, binocular UIVA of 0.13 ± 0.11 logMAR, SE of -0.08 ± 0.38 D, and cylinder of -0.28 ± 0.34 D. No statistically significant differences were found in achieving spectacle independence and there were high levels of satisfaction in both groups.Conclusions: In this retrospective analysis with more than 5,000 patients, both the toric and non-toric RayOne Trifocal IOL models provided good visual performance at all distances, resulting in excellent levels of spectacle independence and patient satisfaction. [J Refract Surg. 2024;40(7):e468-e479.].","PeriodicalId":16951,"journal":{"name":"Journal of refractive surgery","volume":"40 7","pages":"e468-e479"},"PeriodicalIF":2.9000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of refractive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/1081597X-20240517-01","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To assess visual and refractive outcomes and visual function after bilateral RayOne Trifocal toric and nontoric intraocular lens (IOL) (Rayner) implantation in patients with presbyopia.

Methods: Charts of patients with presbyopia who underwent refractive lens exchange with bilateral implantation of the RayOne Trifocal IOL (toric and non-toric) were retrospectively reviewed. Visual and refractive outcomes were evaluated at 3 months. Patient satisfaction, spectacle independence, and visual disturbance profile were assessed by questionnaires.

Results: A total of 5,226 patients were assigned to one of two groups: 1,010 patients had toric IOL implantation (toric group) and 4,216 patients received the non-toric model (non-toric group). Mean ± standard deviation visual acuity at 3 months for the toric group was binocular uncorrected distance visual acuity (UDVA) of 0.07 ± 0.11 logMAR, monocular corrected distance visual acuity (CDVA) of 0.05 ± 0.07 logMAR, binocular uncorrected near visual acuity (UNVA) at 40 cm of 0.10 ± 0.09 logMAR, binocular uncorrected intermediate visual acuity (UIVA) at 40 cm of 0.13 ± 0.12 logMAR, postoperative spherical equivalent (SE) of -0.21 ± 0.47 diopters (D), and cylinder of -0.34 ± 0.40 D. The non-toric group had binocular UDVA of 0.04 ± 0.08 logMAR, monocular CDVA of 0.05 ± 0.07 logMAR, binocular UNVA of 0.10 ± 0.08 logMAR, binocular UIVA of 0.13 ± 0.11 logMAR, SE of -0.08 ± 0.38 D, and cylinder of -0.28 ± 0.34 D. No statistically significant differences were found in achieving spectacle independence and there were high levels of satisfaction in both groups.

Conclusions: In this retrospective analysis with more than 5,000 patients, both the toric and non-toric RayOne Trifocal IOL models provided good visual performance at all distances, resulting in excellent levels of spectacle independence and patient satisfaction. [J Refract Surg. 2024;40(7):e468-e479.].

查看原文本刊更多论文

5,226 名老花眼患者使用三焦点眼内透镜进行双侧屈光晶体置换后的视觉效果和患者满意度。

目的：评估老花眼患者双侧RayOne三焦点散光和非散光人工晶体（IOL）（雷纳）植入术后的视觉和屈光效果以及视觉功能：方法：对接受屈光性晶状体置换术并双侧植入雷诺三焦点人工晶体（散光和非散光）的老花眼患者的病历进行了回顾性审查。在 3 个月后对视觉和屈光效果进行了评估。通过问卷调查评估了患者的满意度、配戴眼镜的独立性以及视力障碍情况：共有 5,226 名患者被分配到两组中的一组：1,010 名患者植入了散光人工晶体（散光组），4,216 名患者接受了非散光模型（非散光组）。散光组 3 个月时的平均视力（标准差）为：双眼未校正远距离视力 (UDVA) 0.07 ± 0.11 logMAR，单眼校正远距离视力 (CDVA) 0.05 ± 0.07 logMAR，双眼未校正远距离视力 (UDVA) 0.07 ± 0.11 logMAR，单眼校正远距离视力 (CDVA) 0.05 ± 0.07 logMAR。07 logMAR，40 厘米处双眼未校正近视力 (UNVA) 为 0.10 ± 0.09 logMAR，40 厘米处双眼未校正中间视力 (UIVA) 为 0.13 ± 0.12 logMAR，术后球面等效视力 (SE) 为 -0.无晶体眼组的双眼 UDVA 为 0.04 ± 0.08 logMAR，单眼 CDVA 为 0.05 ± 0.07 logMAR，双眼 UNVA 为 0.10 ± 0.08 logMAR，双眼 UIVA 为 0.13 ± 0.11 logMAR，SE 为 -0.在实现眼镜独立方面没有发现显著的统计学差异，两组患者的满意度都很高：在这项对 5000 多名患者进行的回顾性分析中，散光型和非散光型 RayOne 三焦点人工晶体在所有距离上都提供了良好的视觉表现，从而实现了极佳的眼镜独立性和患者满意度。[J Refract Surg. 2024;40（7）：e468-e479]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

$Journal of refractive surgery$

Journal of refractive surgery 医学-外科

CiteScore

5.10

自引率

12.50%

发文量

160

审稿时长

4-8 weeks

期刊介绍： The Journal of Refractive Surgery, the official journal of the International Society of Refractive Surgery, a partner of the American Academy of Ophthalmology, has been a monthly peer-reviewed forum for original research, review, and evaluation of refractive and lens-based surgical procedures for more than 30 years. Practical, clinically valuable articles provide readers with the most up-to-date information regarding advances in the field of refractive surgery. Begin to explore the Journal and all of its great benefits such as: • Columns including “Translational Science,” “Surgical Techniques,” and “Biomechanics” • Supplemental videos and materials available for many articles • Access to current articles, as well as several years of archived content • Articles posted online just 2 months after acceptance.